Arnaiz; Damian O.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arnaiz; Damian O..The latest application filed is for "diamine derivatives as inhibitors of leukotriene a4 hydrolase".

Company Profile

1.22.20

Arnaiz; Damian O. - El Sobrante CA
Arnaiz; Damian O - El Sobrante CA
Arnaiz; Damian O. - Hercules CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 11,267,819 - Arnaiz , et al. March 8, 2	2022-03-08
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20200308181 - Arnaiz; Damian O. ; et al.	2020-10-01
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20180230159 - Arnaiz; Damian O. ; et al.	2018-08-16
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20160272649 - Arnaiz; Damian O. ; et al.	2016-09-22
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 9,315,509 - Arnaiz , et al. April 19, 2	2016-04-19
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20150080382 - Arnaiz; Damian O. ; et al.	2015-03-19
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 8,569,303 - Arnaiz , et al. October 29, 2	2013-10-29
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20130123243 - Arnaiz; Damian O. ; et al.	2013-05-16
Thiazolidinones, their production and use as pharmaceutical agents Grant 7,511,059 - Schulze , et al. March 31, 2	2009-03-31
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents Grant 7,504,410 - Bryant , et al. March 17, 2	2009-03-17
Imidazolidinedione analogs useful as anticoagulants and antithrombotics Grant 7,199,146 - Arnaiz , et al. April 3, 2	2007-04-03
Thiazolidinones, their production and use as pharmaceutical agents App 20060223833 - Schulze; Volker ; et al.	2006-10-05
Piperidine derivatives and their use as anti-inflammatory agents App 20060167044 - Arnaiz; Damian O. ; et al.	2006-07-27
Imidazolidinedione analogs useful as anticoagulants and antithrombotics App 20060142363 - Arnaiz; Damian O. ; et al.	2006-06-29
Imidazolidinedione analogs useful as anticoagulants and antithrombotics Grant 7,053,112 - Arnaiz , et al. May 30, 2	2006-05-30
N-heterocyclic derivatives as NOS inhibitors Grant 6,887,865 - Arnaiz , et al. May 3, 2	2005-05-03
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,368 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,263 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,849,739 - Arnaiz , et al. February 1, 2	2005-02-01
N-heterocyclic derivatives as NOS inhibitors Grant 6,846,829 - Arnaiz , et al. January 25, 2	2005-01-25
N-heterocyclic derivatives as NOS inhibitors Grant 6,841,674 - Arnaiz , et al. January 11, 2	2005-01-11
N-heterocyclic derivatives as nos inhibitors Grant 6,841,673 - Arnaiz , et al. January 11, 2	2005-01-11
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents App 20040186118 - Bryant, Judi ; et al.	2004-09-23
Imidazolidinedione analogs useful as anticoagulants and antihrombotics App 20040122073 - Arnaiz, Damian O. ; et al.	2004-06-24
N-heterocyclic derivatives as NOS inhibitors Grant 6,747,031 - Arnaiz , et al. June 8, 2	2004-06-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,670,473 - Arnaiz , et al. December 30, 2	2003-12-30
N-heterocyclic derivatives as NOS inhibitors App 20030092678 - Arnaiz, Damian O. ; et al.	2003-05-15
N-heterocyclic derivatives as NOS inhibitors App 20030083332 - Arnaiz, Damian O. ; et al.	2003-05-01
N-heterocyclic derivatives as NOS inhibitors App 20030078265 - Arnaiz, Damian O. ; et al.	2003-04-24
N-heterocyclic derivatives as NOS inhibitors App 20030073669 - Arnaiz, Damian O. ; et al.	2003-04-17
N-heterocyclic derivatives as NOS inhibitors App 20030069210 - Arnaiz, Damian O. ; et al.	2003-04-10
N-heterocyclic derivatives as NOS inhibitors App 20030060452 - Arnaiz, Damian O. ; et al.	2003-03-27
N-heterocyclic derivatives as NOS inhibitors App 20030027794 - Arnaiz, Damian O. ; et al.	2003-02-06
N-heterocyclic derivatives as NOS inhibitors App 20030004137 - Arnaiz, Damian O. ; et al.	2003-01-02
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,498,185 - Arnaiz , et al. December 24, 2	2002-12-24
N-heterocyclic derivatives as NOS inhibitors App 20020183323 - Arnaiz, Damian O. ; et al.	2002-12-05
N-heterocyclic derivatives as NOS inhibitors App 20020165203 - Arnaiz, Damian O. ; et al.	2002-11-07
N-heterocyclic derivatives as NOS inhibitors Grant 6,432,947 - Arnaiz , et al. August 13, 2	2002-08-13
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,380,221 - Arnaiz , et al. April 30, 2	2002-04-30
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,140,351 - Arnaiz , et al. October 31, 2	2000-10-31
Naphthyl-substituted benzimidazole derivatives as anti-coagulants Grant 5,849,759 - Arnaiz , et al. December 15, 1	1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.